Accessibility Menu
Arrow-Thin-Down
S&P 500
6,791.69
+0.8%
+53.25
Arrow-Thin-Down
DJI
47,207.12
+1.0%
+472.51
Arrow-Thin-Down
NASDAQ
23,204.87
+1.1%
+263.07
Arrow-Thin-Down
Bitcoin
$111,564.00
+0.4%
+$428.13
Arrow-Thin-Down
AAPL
$262.83
+1.3%
+$3.25
Arrow-Thin-Down
AMZN
$224.25
+1.4%
+$3.16
Arrow-Thin-Down
GOOG
$260.59
+2.7%
+$6.86
Arrow-Thin-Down
META
$738.36
+0.6%
+$4.36
Arrow-Thin-Down
MSFT
$523.61
+0.6%
+$3.05
Arrow-Thin-Down
NVDA
$186.29
+2.3%
+$4.13
Arrow-Thin-Down
TSLA
$433.88
-3.4%
-$15.10
Daily Stock GainersDaily Stock LosersMost Active Stocks
ETF Series Solutions - Range Cancer Therapeutics ETF Stock Quote

ETF Series Solutions - Range Cancer Therapeutics ETF (NASDAQ: CNCR)

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price
$0.00
Daily Change
(-) $0.00
Day's Range
$0.00 - $0.00
Previous Close
$0.00
Open
$0.00
Beta
0
Volume
-
Average Volume
-
Sector
Financials
Market Cap
-
Market Cap / Employee
-
52wk Range
$0.00 - $0.00
Revenue
-
Gross Margin
-
Dividend Yield
-
EPS
$0.00
CAPs Rating
-
Industry
Capital Markets

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

ETF Series Solutions - Range Cancer Therapeutics ETF Company Info

Loncar Cancer Immunotherapy ETF

News & Analysis

Featured Article

3 Index Funds to Buy in August

Our contributors take a look at three index funds in promising areas such as emerging markets, cancer immunotherapy, and banks.

Andrés Cardenal, Jason Hall, and George Budwell  |  Aug 1, 2016
Featured Article

3 High-Growth ETFs to Supercharge Your Portfolio

Exposing your portfolio to high-growth industries while staying diversified is a way to boost your portfolio with less risk.

Cory Renauer, Matt Frankel, and Brian Feroldi  |  Jun 1, 2016

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services